Stockholm Medical Cannabis Conference
At Clarion Hotel Sign
27 maj 2022
Participants & Speakers
Stockholm Medical Cannabis Conference (SMCC 2022) proudly presents
conference participants and speakers coming to Stockholm on 27 May and
tells more about Medical Cannabis:
Cornelia Jakobs has after her entrance in the Melodifestivalen and Eurovision Turin 2022 with the song ”Hold Me Closer” brought the whole of Sweden and Europe with it storm. Cornelia is the artist’s soul who has released her music independently since 2018 – songs that she herself calls ”dynamic emotion-surging live music ”. Now she takes the next step. With several releases planned below year and with a dreamy voice that has the ability to move mountains as well melting hearts, there is nothing to say but that success story that spelled Cornelia Jakobs has just begun.
Cornelia debuted in 2018 with ”Late Night Stories” and has become praised with the words ”perfect pop about the power of the moment” and stood for music for the HBO series ”Björnstad” with the song ”Weight of the World”.
Pauline Burke Claseon has many years of experience as a harpist at various events, events and concerts. She studies classical music at the Royal Academy of Music in Stockholm and masters classical, pop, medieval music, folk music from different cultures and much more. Pauline has visited well-known stages in the Nordic countries and among the merits is also a performance in front of the royal couple at Djursholm Castle.
Andrew DeAngelo, Cannabis Industry Consultant and Strategic Advisor, Co-founder of Harborside & Last Prisoner Project, Founder of Andrew DeAngelo Consulting
Andrew DeAngelo is a visionary leader with a proven track record of enacting systemic social change and developing best practices in cannabis — he is the very definition of a trailblazer and someone who has proudly walked the road less traveled.
Marco Perduca, former Italian Senator (2008 to 2013) served on the Foreign Affairs, Justice, and Human Rights committees. For 20 years, he has coordinated the activities of the Nonviolent Radical Party at the United Nations in New York, Geneva and Vienna and has organized high-level meetings to abolish the death penalty in Africa and Central Asia. An expert on UN mechanisms with an emphasis on drug policy reform, Mr. Perduca has collaborated with British law firms and U.S. foundations on prisons and migrants’ rights in Italy. His letters and opinions have appeared in the International Herald Tribune, the Financial Times, The Wall Street Journal, The Guardian and Nature Italy. When in Parliament, he was often a guest on the BBC as a commentator on Italian politics. He has published three books and curated three. He has a blog on HuffingtonPost.it and in 2018 published a memoir, Farnesina Radicale on his international work. In 2021 he was appointed Sherpa of the Values 20 Group and presided over Italy’s Cannabis Referendum Committee.
Stefan Brosellid, Pharmacologist, will tell in detail about the Endocannabinoid system and how it works purely molecularly in the body during pharmacotherapy with medical cannabis. Stefan Broselid, Ph.D. in molecular pharmacology. Scientific advisor for Aureum Healthcare with a burning interest in continuing education within the impact of the endocannabinoid system on health and disease.
Thomas Skovlund Schnegelsberg is the CEO and co-founder of STENOCARE A/S. He holds a master’s degree from Copenhagen Business School with specialty in Strategy and Quality Management and has served +20 years in leading positions for Microsoft in Denmark, Scandinavia, UK and Europe.
STENOCARE was founded in 2017 and is a Danish cultivator and supplier of prescription-based medical cannabis products for patients in Denmark, Sweden and soon the UK. It was the first and only company in Denmark to have medical cannabis oil products approved in 2018 and in Sweden in 2020. The company has a pharma-mentality to production, and a proven track record to work with the Medicines Agencies in several European countries.
Tina Horsted, MD, Horsted Institute, who is a specialist in anesthesia and pain treatment, Denmark’s first and leading specialist in pain treatment with medical cannabis and owner of the Pain Clinic in Copenhagen. Tina Horsted has worked for 20 years as a doctor, chief physician and specialist in anaesthesiology, intensive care medicine and pain treatment. Tina Horsted holds an SSAI (The Scandinavian Society of Anesthesiology and Intensive Care Medicine) degree in pain management.
Robert Rademaker is responsible for managing the legal activities of Bedrocan. He deals with legal risk management, and ensures compliance with applicable legislation and regulations. Robert is a trusted advisor to Bedrocan’s senior management and secretary to the Board of Directors.
Monique van Velzen, Intituut Medical Cannabis, is an assistant professor and research coordinator at the Leiden University Medical Center. She conducts team research into chronic pain and – ultimately – the most appropriate way to treat people with chronic pain. She is also a board member of the Institute for Medicinal Cannabis (see below).
Julie Moltke, MD is a medical doctor with a focus on mental health, stress management, and the medicinal cannabis industry. She is the author of “A Quick Guide to CBD” and the founder and former editor of the London-based health, wellness, and cannabis science publication, Getthedose, as well as The Holistic Medicine Podcast.
Bent Damgaard, MD. Specialist in general medicine at Klinik Slotssøen, Kolding. Has been a general practitioner in Kolding 1987–2018. Former diploma in sports medicine and doctor for Denmark’s alpine talent national team and Denmark’s skater national team. Educated in cannabis as a medicine via conferences and courses in Germany, Spain, Austria and Canada, among others, and a clinic stay with the pain specialist Tina Horsted, Copenhagen. Has since 2018 even today worked with medical cannabis at Klinik Horsted, Kolding.
Christopher Kainz is Managing Director France & Associate Director EU Business Development Aurora Europe GmbH. He has been with Aurora for almost 3 years, and has contributed to leading strategic, commercial and operational projects and initiatives across Europe, such as the French pilot program. Prior to joining Aurora Europe, Chris spent 3 years in Financial Services Strategy at Parthenon-EY in London.
Peter Emil Sigetty is co-founder and COO of Valcon Medical. Peter holds a M.S.c in Economics & Business Administration and has a professional background in finance and accounting. Peter has worked in the medical cannabis industry since it’s inception in Denmark in 2018 where Valcon Medical was founded.
Valcon Medical is a Danish-based contract manufacturing organization offering a complete outsourcing solution for the manufacturing of medical cannabis extracts.
Jeppe Krog Rasmussen is one of the founders of Dancann which is a listed manufacturer (grower) of medical cannabis. Krog Rasmussen has been awarded prizes for his entrepreneurship and is probably the world’s youngest and one of the most successful directors working in the medical cannabis industry, with a bright future ahead of him.
Moa Lily works as a writer and reporter for the news site Cannabis in Focus. Her focus is on spreading awareness and knowledge about medical cannabis and highlighting patients’ voices
During the conference, she will, among other things, interview several medical cannabis patients where they will have the chance to share their history.
Christian Engström was an EU parliamentarian for the Pirate Party between 2009 and 2014 with a focus on issues related to freedom on the internet. Since his time in the European Parliament, he has been committed to a fact-based drug policy. He is a columnist for Cannabis in Focus.
Angelica Örnell is Head of Operations at Sweden’s first pain clinic, Aureum Healthcare, which uses pharmacotherapy with Medical Cannabis as part of treatment for pain, tremors and care caused by opioid dependence and injury.
Lena Dager is a Research Nurse with long and broad experience of Clinical Trials. Lena has previously been responsible for coordinating clinical trials in Phases 1-4, including FIM (First in Man) within most diagnostic groups and with healthy volunteers.
At Aureum Healthcare, Lena works as deputy operations manager and legal nurse. In the autumn, it is planned that Lena will also set up research projects for Aureum.
SMCC 2022 aims to inform by educating
the pharmaceutical industry, patient organizations and the Swedish
health care in pharmacotherapy with Medical Cannabis-based
preparations for difficult-to-treat pain and tremors. Stockholm Medical
Cannabis Conference, SMCC 2022 is organized by the Swedish Investment company Aureum Life AB and the news site Cannabis in Focus.
Stockholm Medical Cannabis Conference (SMCC 2022) is one
industry-specific closed meeting with paid admission for invited and
Biljett köper du här: